Evaluation of the Migrastatic Properties of Selective MMP-2
                    Inhibitors in Colorectal Cancer: An In Ovo Approach

Nikunj Parekh; Mansi Patel; Praysha Patel; Disha Patel; Kirtan Patel; Krishna Thakkar; Aarti Parmar; Umang Shah; Sahil Panjvani; Samir Patel; Alkeshkumar Kiritbhai Patel

doi:10.1055/a-2724-6878

Drug Research, Table of Contents

Drug Res (Stuttg)
DOI: 10.1055/a-2724-6878

Original Article

Evaluation of the Migrastatic Properties of Selective MMP-2 Inhibitors in Colorectal Cancer: An In Ovo Approach

Authors

Nikunj Parekh

¹Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, India (Ringgold ID: RIN130172)
Mansi Patel

¹Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, India (Ringgold ID: RIN130172)
Praysha Patel

²University of Windsor, Windsor, Canada (Ringgold ID: RIN8637)
Disha Patel

¹Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, India (Ringgold ID: RIN130172)
Kirtan Patel

¹Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, India (Ringgold ID: RIN130172)
Krishna Thakkar

¹Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, India (Ringgold ID: RIN130172)
Aarti Parmar

¹Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, India (Ringgold ID: RIN130172)
Umang Shah

¹Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, India (Ringgold ID: RIN130172)
Sahil Panjvani

³Department of Histopathology, Vadodara Clinical Laboratory, Vadodara, India
Samir Patel

¹Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, India (Ringgold ID: RIN130172)
Alkeshkumar Kiritbhai Patel

¹Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, India (Ringgold ID: RIN130172)

Abstract

ABSTRACT

Colorectal cancer accounts for about 10% of all cancer diagnoses and is the second leading cause of cancer-related death. Until the cancer has progressed to an advanced stage, colorectal cancer typically shows no symptoms. The medications currently utilized to treat colorectal cancer have serious drawbacks. The aim of the study was to evaluate the ability of newly developed synthetic matrix metalloprotease-2 inhibitors to prevent metastases. This study used computational models to evaluate pharmacokinetic characteristics and ligand-binding affinities for preliminary screening. Later, we used the human colorectal cancer cell line SW620 in an in ovo approach to assess its anti-migratory properties. The chorioallantoic membrane was used to transplant tumor cells. In order to assess migrastatic activity in a preclinical model using an in ovo technique, we measured changes in the chick embryo's total body weight, colon length and body weight, complete blood count and histopathology of the colon, liver and stomach. In addition, the histology of the stomach, liver, colon, and chorioallantoic membrane was taken into account while assessing the activity. We discovered that compound N5 ({4-[(3′-amino[1,1′-biphenyl]-4-carbonyl) amino] phenyl~acetic acid) had the best migrastatic action by blocking matrix metalloprotease-2. The new compound showed potential as a matrix metalloprotease-2 inhibitor compared to doxycycline. A more robust platform was needed for further investigation and progress of novel compound towards clinical setting.

Keywords

Colorectal cancer - metastasis - matrix metalloprotease - chicken egg

Full Text

References

References
1 Averbach M, Tebet EN, Moura EGH. Colorectal cancer: global and Brazilian perspectives, prevention, and the impact of the Blue March Campaign. Arq Gastroenterol 2025; 62 (01) 1-3
2 Ciardiello F, Ciardiello D, Martini G, Napolitano S, Tabernero J, Cervantes A. Clinical management of metastatic colorectal cancer in the era of precision medicine. CA Cancer J Clin 2022; 72 (04) 372-401
3 Chandra P, Sacks GD. Contemporary surgical management of colorectal liver metastases. Cancers 2024; 16 (05) 941
4 Martin J, Petrillo A, Smyth EC, Shaida N, Khwaja S, Cheow HK. et al. Colorectal liver metastases: current management and future perspectives. World J Clin Oncol 2020; 11 (10) 761-774
5 Cervantes A, Adam R, Roselló S, Arnold D, Normanno N, Taïeb J. et al. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 2023; 34 (01) 10-32
6 Pretzsch E, Bösch F, Neumann J, Ganschow P, Bazhin A, Guba M. et al. Mechanisms of metastasis in colorectal cancer and metastatic organotropism: hematogenous versus peritoneal spread. J Oncol 2019; 2019: 7407190
7 Seyfried TN, Huysentruyt LC. On the origin of cancer metastasis. Crit Rev Oncog 2013; 18 (1/2) 43-73
8 Hu YY, Zheng MH, Zhang R, Liang YM, Han H. Notch signaling pathway and cancer metastasis. Notch signaling in embryology and cancer. New York: Springer; 2012. pp. 186-198
9 Guan X. Cancer metastases: challenges and opportunities. Acta Pharm Sin B 2015; 5 (05) 402-418
10 Bouchalova P, Bouchal P. Current methods for studying metastatic potential of tumor cells. Cancer Cell Int 2022; 22 (01) 1-22
11 Kue CS, Tan KY, LaM ML, Lee HB. Chick embryo chorioallantoic membrane (CAM): an alternative predictive model in acute toxicological studies for anticancer drugs. Exp Anim 2015; 64 (02) 129-138
12 Garcia P, Wang Y, Viallet J, Macek Jilkova Z. The chicken embryo model: a novel and relevant model for immune based studies. Front Immunol 2021; 12: 791081
13 Liu Y, Wu W, Cai C, Zhang H, Shen H, Han Y. Patient derived xenograft models in cancer therapy: technologies and applications. Signal Transduct Target Ther 2023; 8 (01) 160
14 Lokman NA, Ricciardelli C, Oehler MK. Chick chorioallantoic membrane assay: a 3D animal model for cancer invasion and metastasis. Anim Biotechnol 2020; 31 (03) 221-231
15 Piawah S, Venook AP. Targeted therapy for colorectal cancer metastases: a review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer. Cancer 2019; 125 (23) 4139-4147
16 Čermák V, Dostál V, Jelínek M, Libusová L, Kovář J, Rösel D. et al. Microtubule-targeting agents and their impact on cancer treatment. Eur J Cell Biol 2020; 99 (04) 151075
17 Gandalovičová A, Rosel D, Fernandes M, Veselý P, Heneberg P, Čermák V. et al. Migrastatics—antimetastatic and anti-invasion drugs: promises and challenges. Trends Cancer 2017; 3 (06) 391-406
18 Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin 2023; 73 (01) 233-254
19 Shoari A, Ashja Ardalan A, Dimesa AM, Coban MA. Targeting invasion: the role of MMP-2 and MMP-9 inhibition in colorectal cancer therapy. Biomolecules 2024; 15 (01) 35
20 Said AH, Raufman JP, Xie G. The role of matrix metalloproteinases in colorectal cancer. Cancers 2014; 6 (01) 366-375
21 Winer A, Adams S, Mignatti P. Matrix metalloproteinase inhibitors in cancer therapy: turning past failures into future successes. Mol Cancer Ther 2018; 17 (06) 1147-1155
22 Tune BX, Sim MS, Poh CL, Guad RM, Woon CK, Hazarika I. et al. Matrix metalloproteinases in chemoresistance: regulatory roles, molecular interactions, and potential inhibitors. J Oncol 2022; 2022: 3249766
23 Shoari A, Ashja Ardalan A, Dimesa AM, Coban MA. Targeting invasion: the role of MMP-2 and MMP-9 Inhibition in colorectal cancer therapy. Biomolecules 2024; 15 (01) 35
24 Waschkies CF, Pfiffner FK, Heuberger DM, Schneider MA, Tian Y, Wolint P. et al. Tumor grafts grown on the chicken chorioallantoic membrane are distinctively characterized by MRI under functional gas challenge. Sci Rep 2020; 10 (01) 7505
25 Shen LC, Chen YK, Lin LM, Shaw SY. Anti-invasion and anti-tumor growth effect of doxycycline treatment for human oral squamous cell carcinoma: in vitro and in vivo studies. Oral Oncol 2010; 46 (03) 178-184
26 Bounaama A, Djerdjouri B. Matrix metalloproteinase 9 implication during colorectal carcinogenesis. Effect of doxycycline. Fundam Clin Pharmacol 2025; 39 (03) e70012
27 Patel SG, Patel A, Patel N, Raiya B, Vora H, Jain N. Investigating the resistance mechanism of 5-fluorouracil in colorectal cancer based on surface markers of cancer stemness and cytokine level: A pre-clinical study. J Cancer Res Ther 2023; 19 Suppl 2 S560-S568
28 Radenković N, Nikodijević D, Jovankić J, Blagojević S, Milutinović M. Resistance to 5-fluorouracil: The molecular mechanisms of development in colon cancer cells. Eur J Pharmacol 2024; 983: 176979
29 Shankar A, Wang JJ, Rochtchina E, Yu MC, Kefford R, Mitchell P. Association between circulating white blood cell count and cancer mortality: a population based cohort study. Arch Intern Med 2006; 166 (02) 188-194
30 Lee YJ, Lee HR, Nam CM, Hwang UK, Jee SH. White blood cell count and the risk of colon cancer. Yonsei Med J 2006; 47 (05) 646
31 Constantinescu AE, Bull CJ, Jones N, Mitchell R, Burrows K, Dimou N. et al. Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation study. Int J Cancer 2024; 154 (01) 94-103
32 Mazaki J, Katsumata K, Kasahara K, Tago T, Wada T, Kuwabara H. et al. Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer: a propensity score analysis. BMC cancer 2020; 20 (01) 922
33 Idos GE, Kwok J, Bonthala N, Kysh L, Gruber SB, Qu C. The prognostic implications of tumor infiltrating lymphocytes in colorectal cancer: a systematic review and meta-analysis. Sci Rep 2020; 10 (01) 3360
34 Ogino S, Nosho K, Irahara N, Meyerhardt JA, Baba Y, Shima K. et al. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res 2009; 15 (20) 6412-6420
35 Ko YS, Pyo JS. Clinicopathological significance and prognostic role of tumor infiltrating lymphocytes in colorectal cancer. Int J Biol Markers 2019; 34 (02) 132-138
36 Benčurová K, Tran L, Friske J, Bevc K, Helbich TH, Hacker M. et al. An in vivo tumour organoid model based on the chick embryonic chorioallantoic membrane mimics key characteristics of the patient tissue: a proof-of-concept study. EJNMMI Res 2024; 14 (01) 86
37 Palaniappan TK, Šlekienė L, Jonasson AK, Gilthorpe J, Gunhaga L. CAM-Delam: an in vivo approach to visualize and quantify the delamination and invasion capacity of human cancer cells. Sci Rep 2020; 10 (01) 10472
38 Augustine R, Alhussain H, Hasan A, Ahmed MB, Yalcin HC, Al Moustafa AE. A novel in ovo model to study cancer metastasis using chicken embryos and GFP expressing cancer cells. Bosn J Basic Med Sci 2020; 20 (01) 140
39 Waschkies CF, Pfiffner FK, Heuberger DM. et al. Tumor grafts grown on the chicken chorioallantoic membrane are distinctively characterized by MRI under functional gas challenge. Sci Rep 2020; 10 (01) 7505
40 Patel A, Vora H, Jain N, Nandpal M, Panjvani S, Patel S. Evaluating the Immunomodulatory and Detoxifying role of Tinospora cordifolia and Solanum nigrum in the treatment of Colorectal Cancer. Res J Pharm Technol 2024; 17 (05) 2155-2163

Supplementary Material

Supplementary Material (PDF) (opens in new window)